Inhibitors of Phosphodiesterase Isoforms III or IV Suppress Islet-Cell Nitric Oxide Production-Reference-Cited by-同舟云学术

Inhibitors of Phosphodiesterase Isoforms III or IV Suppress Islet-Cell Nitric Oxide Production

Published:2001-08 Issue:8 Volume:81 Page:1109-1117
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Beshay Evette,Prud'homme Gérald J

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3780323.pdf

Reference39 articles.

1. Andersen HU, Mauricio D, Karlsen AE, Mandrup-Poulsen T, Nielsen JH, and Nerup J (1996). Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine. Eur J Endocrinol 134: 251–259.

2. Badger AM, Olivera DL, and Esser KM (1994). Beneficial effects of phosphodiesterase inhibitors BRL 61063, pentoxifylline, rolipram in murine models of endotoxic shock. Circ Shock 44: 188–195.

3. Belin VD, Mabley JG, James RF, Swift SM, Clayton HA, Titheradge MA, and Green IC (1999). Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of Langerhans. Cytokine 11: 585–592.

4. Bergmann L, Kroncke KD, Suschek C, and Kolb-Bachofen V (1992). Cytotoxic action of IL-1β against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine. FEBS Lett 299: 103–106.

5. Beshay E, Croze F, and Prud'homme GJ (2001). The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol 98: 272–279.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus;Medicinal Chemistry;2024-06

2. Role of Phosphodiesterase in the Biology and Pathology of Diabetes;International Journal of Molecular Sciences;2020-11-03

3. Beta-3 Adrenoceptor Signaling Pathways in Urothelial and Smooth Muscle Cells in the Presence of Succinate;Journal of Pharmacology and Experimental Therapeutics;2018-08-13

4. Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP;International Immunopharmacology;2018-03

5. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes;Regulatory Peptides;2011-10